Norah Slattery is an accomplished regulatory affairs executive with extensive experience in the biopharmaceutical industry. Currently serving as Vice President and Head of Regulatory Affairs CMC at Spark Therapeutics, Inc. since May 2019, Norah has previously held notable positions including Associate Vice President for Global Regulatory Affairs CMC Biologics at Sanofi Genzyme and Senior Director of Global CMC at Pfizer. Norah's career began at Genzyme, where contributions to Quality Control were made, and has included significant roles at Biogen Idec, Wyeth BioPharma, and other leading companies in the sector.
Sign up to view 0 direct reports
Get started